CY1116056T1 - Αντιβακτηριακη θεραπεια συνδυασμου για τη θεραπεια gram θετικων βακτηριακων μολυνσεων - Google Patents

Αντιβακτηριακη θεραπεια συνδυασμου για τη θεραπεια gram θετικων βακτηριακων μολυνσεων

Info

Publication number
CY1116056T1
CY1116056T1 CY20141100959T CY141100959T CY1116056T1 CY 1116056 T1 CY1116056 T1 CY 1116056T1 CY 20141100959 T CY20141100959 T CY 20141100959T CY 141100959 T CY141100959 T CY 141100959T CY 1116056 T1 CY1116056 T1 CY 1116056T1
Authority
CY
Cyprus
Prior art keywords
treatment
combination therapy
bacterial infections
gram positive
positive bacterial
Prior art date
Application number
CY20141100959T
Other languages
English (en)
Inventor
Malcolm Philip Young
Catherine Mary Thomas
Original Assignee
E-Therapeutics Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E-Therapeutics Plc filed Critical E-Therapeutics Plc
Publication of CY1116056T1 publication Critical patent/CY1116056T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Περιγράφεται μία σύνθεση περιλαμβάνουσα θεραπευτικώς δραστικό ιμιδαζόλιο και παράγωγα αυτού και έναν παράγοντα δραστικό επί επιφανείας βακτηριακού κυττάρου που επιλέγεται από την ομάδα που αποτελείται από ένα ή περισσότερα από κολιστίνη, νισίνη, D-κυκλοσερίνη, φωσφομυκίνη, τρομεταμόλη φωσφομυκίνης, δινάτριο άλας φωσφομυκίνης και πολυμιξίνη Β και παράγωγα αυτών.
CY20141100959T 2008-07-18 2014-11-17 Αντιβακτηριακη θεραπεια συνδυασμου για τη θεραπεια gram θετικων βακτηριακων μολυνσεων CY1116056T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0813211.0A GB0813211D0 (en) 2008-07-18 2008-07-18 Antibacterial combination therapy for the treatment of gram positive bacterial infections
EP09784726.3A EP2328573B1 (en) 2008-07-18 2009-07-17 Antibacterial combination therapy for the treatment of gram positive bacterial infections

Publications (1)

Publication Number Publication Date
CY1116056T1 true CY1116056T1 (el) 2017-02-08

Family

ID=39737300

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100959T CY1116056T1 (el) 2008-07-18 2014-11-17 Αντιβακτηριακη θεραπεια συνδυασμου για τη θεραπεια gram θετικων βακτηριακων μολυνσεων

Country Status (15)

Country Link
US (1) US8614179B2 (el)
EP (1) EP2328573B1 (el)
JP (1) JP6023425B2 (el)
CN (1) CN102112125B (el)
AU (1) AU2009272485B2 (el)
CA (1) CA2730826A1 (el)
CY (1) CY1116056T1 (el)
DK (1) DK2328573T3 (el)
ES (1) ES2523968T3 (el)
GB (1) GB0813211D0 (el)
HR (1) HRP20141147T1 (el)
PL (1) PL2328573T3 (el)
PT (1) PT2328573E (el)
WO (1) WO2010007381A1 (el)
ZA (1) ZA201100705B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2508231A3 (en) * 2006-11-16 2012-10-17 E-Therapeutics Plc Imidazoles for treating multi-drug resistant bacterial infections
GB0714226D0 (en) * 2007-07-20 2007-08-29 Therapeutics Ltd E anti-bacterial combination therapy
GB0813211D0 (en) 2008-07-18 2008-08-27 E Therapeutics Plc Antibacterial combination therapy for the treatment of gram positive bacterial infections
BRPI0904249B1 (pt) 2009-08-28 2018-03-06 Biolab Sanus Farmacêutica Ltda. Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica
US10471083B2 (en) 2011-07-12 2019-11-12 Savara Inc. Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
WO2014052836A2 (en) 2012-09-27 2014-04-03 Dunman Paul M Methods and compositions for treating infection
US9662372B2 (en) 2013-02-20 2017-05-30 Biolog, Inc. Compositions and methods to inactivate and/or reduce production of microbial toxins
GB201305277D0 (en) * 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
RU2549447C1 (ru) * 2014-03-14 2015-04-27 Алексей Игоревич Панюков Противовоспалительное антибактериальное ранозаживляющее средство
DE102014218913A1 (de) * 2014-09-19 2016-03-24 Heraeus Medical Gmbh Verfahren zur Herstellung eines antibiotischen Polymehtylmethacrylat-Knochenzementpulvers und ein antibiotisches Polymethtylmethacrylat-Knochenzementpulver
CN106377757B (zh) * 2016-03-04 2020-05-19 广州英赛特生物技术有限公司 含氧碳氢衍生物作为多粘菌素的协同增效剂的应用
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
US10485790B1 (en) * 2018-09-13 2019-11-26 Syneurx International (Taiwan) Corp. Salts of cycloserine compounds and applications thereof
WO2022257105A1 (en) * 2021-06-11 2022-12-15 The Hong Kong Polytechnic University Methods for treating bacterial cell populations
US20230062900A1 (en) * 2021-08-05 2023-03-02 Jonathan SORRES New antibacterial compound isolated from psiloxylon mauritianum and its derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249109A (en) 1963-11-01 1966-05-03 Maeth Harry Topical dressing
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4307717A (en) 1977-11-07 1981-12-29 Lectec Corporation Sterile improved bandage containing a medicament
NZ210840A (en) 1984-01-18 1987-05-29 Johnson & Johnson Baby Prod Composition comprising synergistic combination of miconazole nitrate and zinc oxide
US4725439A (en) 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
HU199682B (en) * 1988-04-01 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producin synergetic veterinary composition
GB9224598D0 (en) * 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
JP2875140B2 (ja) 1993-08-16 1999-03-24 明治製菓株式会社 抗ｍｒｓａ組成物
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US7238363B2 (en) 2004-04-02 2007-07-03 Baylor College Of Medicine Modification of medical prostheses
EP2508231A3 (en) * 2006-11-16 2012-10-17 E-Therapeutics Plc Imidazoles for treating multi-drug resistant bacterial infections
GB0714226D0 (en) 2007-07-20 2007-08-29 Therapeutics Ltd E anti-bacterial combination therapy
US20100239682A1 (en) 2007-09-17 2010-09-23 Antoine Andremont Colonic delivery of antimicrobial agents
GB0724996D0 (en) * 2007-12-21 2008-01-30 Therapeutics Ltd E Antibacterial combination therapy for the treatment of gram positive bacterial infections
GB0813211D0 (en) 2008-07-18 2008-08-27 E Therapeutics Plc Antibacterial combination therapy for the treatment of gram positive bacterial infections

Also Published As

Publication number Publication date
JP6023425B2 (ja) 2016-11-09
HRP20141147T1 (hr) 2015-01-30
CN102112125B (zh) 2016-06-22
DK2328573T3 (en) 2014-12-08
AU2009272485B2 (en) 2015-02-12
GB0813211D0 (en) 2008-08-27
ES2523968T3 (es) 2014-12-03
EP2328573A1 (en) 2011-06-08
US8614179B2 (en) 2013-12-24
CA2730826A1 (en) 2010-01-21
AU2009272485A1 (en) 2010-01-21
US20110257078A1 (en) 2011-10-20
EP2328573B1 (en) 2014-08-27
CN102112125A (zh) 2011-06-29
ZA201100705B (en) 2012-04-25
PL2328573T3 (pl) 2015-02-27
JP2012503594A (ja) 2012-02-09
WO2010007381A1 (en) 2010-01-21
PT2328573E (pt) 2014-12-03

Similar Documents

Publication Publication Date Title
CY1116056T1 (el) Αντιβακτηριακη θεραπεια συνδυασμου για τη θεραπεια gram θετικων βακτηριακων μολυνσεων
CY1120796T1 (el) Συνδυασμος φαινοξυβενζαμινης και πολυμυξινης ε για την θεραπευτικη αντιμετωπιση των μικροβιακων λοιμωξεων
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
NZ593004A (en) Azaazulene compounds
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
GEP20156309B (en) Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MX351590B (es) Antibioticos de oxazolidinona.
MX2010008921A (es) Derivados de oxazolidinona.
CR10748A (es) Compuesto de indol
HK1138184A1 (en) Combination medicaments for treating bacterial infections
TW200734344A (en) Antibacterial agents
WO2007084728A3 (en) 2-imino-benzimidazoles
PA8678901A1 (es) Derivados de quinolina como agentes antibacteriales
EA200802111A1 (ru) Имплантаты для лечения состояний, ассоциируемых с допамином
WO2010047737A3 (en) Antimicrobial indoline compounds for treatment of bacterial infections
GEP20156346B (en) Imidazole derivatives as pde10a enzyme inhibitors
EP3216798A3 (en) Ketolide compounds
MX2011008043A (es) Derivados de actagardina.
CY1119402T1 (el) Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
MX2021001564A (es) Diazabiciclooctanonas como inhibidores de serina beta-lactamasas.
CY1118515T1 (el) Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
CY1114384T1 (el) Αντιβακτηριακα παραγωγα κινολινης
WO2008014108A3 (en) Antimicrobial oxazolidinone prodrugs